Columbus Circle Investors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-17,026
Closed -$261K 282
2014
Q1
$261K Buy
+17,026
New +$261K ﹤0.01% 280